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Introduction: Ruptured descending thoracic aortic aneurysm (rDTAA) is associated with high mortality rates. Data
supporting endovascular thoracic aortic aneurysm repair (TEVAR) to reduce mortality compared with open repair are
limited to small series. We investigated published reports for contemporary outcomes of open and endovascular repair of
rDTAA.
Methods: We systematically reviewed all studies describing the outcomes of rDTAA treated with open repair or TEVAR
since 1995 using MEDLINE, Cochrane Library CENTRAL, and Excerpta Medica Database (EMBASE) databases. Case
reports or studies published before 1995 were excluded. All articles were critically appraised for relevance, validity, and
availability of data regarding treatment outcomes. All data were systematically pooled, andmeta-analyses were performed
to investigate 30-day mortality, myocardial infarction, stroke, and paraplegia rates after both types of repair.
Results:Original data of 224 patients (70% male) with rDTAA were identified: 143 (64%) were treated with TEVAR and
81 (36%) with open repair. Mean age was 70 5.6 years. The 30-day mortality was 19% for patients treated with TEVAR
for rDTAA compared 33% for patients treated with open repair, which was significant (odds ratio [OR], 2.15, P .016).
The 30-day occurrence rates of myocardial infarction (11.1% vs 3.5%; OR, 3.70, P < .05), stroke (10.2% vs 4.1%; OR,
2.67; P .117), and paraplegia (5.5% vs 3.1%; OR, 1.83; P .405) were increased after open repair vs TEVAR, but this
failed to reach statistical significance for stroke and paraplegia. Five additional patients in the TEVAR group died of
aneurysm-related causes after 30 days, during a median follow-up of 17  10 months. Follow-up data after open repair
were insufficient. The estimated aneurysm-related survival at 3 years after TEVAR was 70.6%.
Conclusion: Endovascular repair of rDTAA is associated with a significantly lower 30-day mortality rate compared with
open surgical repair. TEVAR was associated with a considerable number of aneurysm-related deaths during follow-up.
(J Vasc Surg 2010;51:1026-32.)The annual incidence of ruptured aneurysm of the
thoracic aorta is about 5 per 100,000, which makes it less
common than ruptured abdominal aortic aneurysms.1,2
Approximately 30% of all ruptured thoracic aortic aneu-
rysms (TAAs) are localized at the descending thoracic
aorta, the remaining ruptured TAAs are found at the as-
cending aorta and arch.1 Overall mortality rates of ruptured
TAAs of up to 97% have been reported, and only a few
patients survive transport to the emergency department.1
The traditional treatment of intact and ruptured aneu-
rysms of the descending thoracic aorta (rDTAA) has been
open surgical resection of the aneurysm and replacement
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1026with an interposition graft, which was first performed by
Lam and Aram in 1951.3 Open surgical repair of the
rDTAA allows inspection of the ruptured aneurysm and
possible aortic branches. However, this approach requires
thoracotomy, aortic cross-clamping, and in some cases,
cardiopulmonary bypass.
Successful endovascular management of a rDTAA was
first reported by Semba et al4 in 1997. Endovascular tho-
racic aortic aneurysm repair (TEVAR) is less invasive than
open repair and may result in quick exclusion of the aneu-
rysmwithout thoracotomy or aortic clamping. Recent non-
randomized trials have demonstrated 30-day mortality
rates of 1.9% to 2.1% after elective TEVAR compared with
5.7% to 11.7% after elective open repair.5-7 In addition,
endovascular repair has been associated with improved
operative mortality rates for ruptured abdominal aortic
aneurysms8,9 and traumatic thoracic aortic ruptures.10,11
However, the exact role of TEVAR for the management of
rDTAA still has to be better defined, as a result of the low
incidence of rDTAA. The purpose of the present study was
to perform a meta-analysis evaluating the outcomes of
endovascular vs open repair for the management of
rDTAA.
METHODS
Literature search. MEDLINE, EMBASE, and Co-
chrane Library CENTRAL were searched until June 29,
2009. The following search string was used for MEDLINE:
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emergen*[tiab] or “acute”[tiab] or perforat*[tiab]) and
(“thoracic”[title] or “descending”[title]) and (“aorta”[title]
or “aortic”[title]) and (“aneurysm”[tiab] or “aneurysms”
[tiab] or “aneurysmatic”[tiab]. This resulted in 846 articles. A
similar search string was used for EMBASE, resulting in 1390
articles. A manual search of the Cochrane library CENTRAL
database did not reveal any relevant articles. After duplicate
articles were removed, 1743 articles remained. No lan-
guage or publication date restrictions were applied.
Article selection. All titles and abstracts were read by
two independent investigators (F.H.J. andB.E.M.). Inclusion
criteria were (1) articles describing patients with rDTAA
treated with TEVAR or open repair; (2) the following
patient outcomes were described: 30-day mortality (re-
quired) and 30-day complications, including stroke, para-
plegia, and myocardial infarction (MI), preferably. Aneu-
rysm rupture was defined as fresh blood outside the aortic
wall on imaging or during surgery. Exclusion criteria in-
cluded (1) articles published before 1995, to guarantee that
the report represents contemporary practice; (2) case re-
ports; (3) thoracic aortic pathologies other than rDTAA,
such as ruptured thoracoabdominal aneurysms, aneurysms
of the ascending aorta or arch, penetrating aortic ulcers, or
pseudoaneurysms; (4) no clear description of outcomes of
TEVAR or open repair; and (5) no original data presented
in the article.
Studies that evaluated other thoracic aortic pathologies
besides rDTAA were excluded, unless treatment outcome
variables were described separately for the different pathol-
Table I. Availability of data in the evaluated reports
Variable available




Contained rupture 191 (85)
Consideration for repair type 224 (100)
Repair 24 hours 177 (79)
Anesthesia type 177 (79)
Cardiopulmonary bypass 45 (56)
Endograft brand 94/143 (66)
Endograft diameter 38/143 (27)
Endograft length 21/143 (15)
30-day mortality 224 (100)
Death during follow-up 116/170 (68)
Days to in-hospital death 30/54 (56)
Days to follow-up death 5/5 (100)
Cause of in-hospital death 42/54 (78)
Cause of follow-up death 5/5 (100)
Paraplegia 203 (91)
Stroke 182 (81)
Myocardial infarction 187 (84)
Vascular reintervention 165 (74)
Endoleak 90/143 (63)
Endograft-related complications 84/143 (59)
Length of follow-up 116/170 (68)
TEVAR, Endovascular thoracic aortic aneurysm repair.ogies. In this manner, many studies had to be excluded foranalysis. Other articles written by identical authors or insti-
tutions were studied in detail and excluded as necessary to
prevent inclusions of duplicate cases. Reports from admin-
istrative databases were not included because administra-
tive data are thought to be less reliable and could have been
published before in other included reports. A total of 28
relevant articles were identified and included in the final
selection (Appendix, online only).4,12-38
Data extraction. Two independent investigators (F.H.J.
and B.E.M.) analyzed the identified articles. The character-
istics extracted included age and gender of patients; comor-
bidities, including aneurysm characteristics such as diame-
ter, contained or free rupture, associated dissection;
presence of hypovolemic shock at admission; time between
diagnosis and aneurysm repair; repair type; consideration for
preferred repair type; cerebrospinal fluid drainage; anesthesia
type; endograft details, including brand, diameter, length, and
number of stent grafts used; successful aneurysm exclusion;
30-day mortality; mortality 30 days; time between aneu-
rysm repair and death; cause of death; permanent paraplegia;
stroke; MI; endograft-related complications, including en-
doleak, graft migration, and fracture; need for vascular
reintervention30 days; length of stay in days, and length
of follow-up in months. All extracted information was
subsequently systematically entered in one database. Orig-
inal data for 224 patients with rDTAA treated with open
repair or TEVARwere identified. Availability of the studied
variables in the evaluated reports is reported in Table I.
Statistical analysis. Statistical analyses were per-
formed (F.H.J.) using SPSS 15.0 software (SPSS Inc, Chi-
TEVAR (n  143)
no. (%)
Open repair (n  81)
no. (%)
111 (78) 32 (40)
72 (50) 21 (26)
135 (94) 56 (69)
143 (100) 81 (100)
131 (92 46 (57)
96 (67) 81 (100)
45 (56)
94 (66) . . .
38 (27) . . .
21 (15) . . .
143 (100) 81 (100)
107/116 (91) 9/54 (17)
20/27 (74) 10/27 (37)
5/5 (100) . . .
24/27 (89) 18/27 (67)
5/5 (100) . . .
130 (91) 73 (90)
123 (86) 59 (73)
142 (99) 45 (56)
121 (85) 44 (54)
90/143 (63) . . .
84/143 (59) . . .
107/116 (91) 9/54 (17)4)cago, Ill) and Comprehensive Meta-Analysis 2 software. In
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denominators reflect only cases reported. The Levene test
for equality of variances was used to assess the variance of
the 30-day mortality, paraplegia, stroke, and MI rates among
the evaluated studies. Equal variances were confirmed for all
evaluated outcome variables. Contingency tables with 2 test
were used to compare categoric outcome variables between
patients treated with open repair and TEVAR, such as
30-day mortality, paraplegia, stroke, and MI occurrence
rates. Continuous variables were compared between both
repair groups using the t test. The estimated aneurysm-
related survival during follow-up was demonstrated using
Kaplan-Meier life table analysis. Differences were consid-
ered statistically significant at values of P  .05 and when
the 95% confidence interval (CI) for the odds ratio (OR)
did not contain 1.
RESULTS
Baseline characteristics. We identified 28 articles de-
scribing 224 patients with rDTAA, including 143 patients
(63.8%) treated with TEVAR and 81 (36.2%) treated with
open repair. Mean age of patients with rDTAA was 70.0
5.6 years, and 65 (69.9%) were men (Table II). Ruptured
aneurysms treated with TEVAR were more frequently con-
tained rather than a free rupture, 75 of 135 (55.6%) vs 24 of
56 (42.9%; P  .110). However, these data were only
available for 85% of patients (Table I).
Aneurysm repair was performed 24 hours in 147 of
177 patients (83.1%). Considerations for offering open
repair were the institution’s standard treatment in 42 pa-
tients (51.9%), endovascular repair was not available for 28
Table II. Baseline characteristics of patients with ruptured
Characteristic
Open repair (n
no. (%) or mea
Age, y 70.2  1.
Male gender 14 (66.7
Contained rupture 24 (42.9
Consideration for repair type
Institution’s standard treatment 42 (51.9
Emergency treatment 0 (0)
Extensive comorbidities 0 (0)
Anatomy 11 (13.6
Only available treatment 28 (34.6
Repair 24 hours 41 (89.1
General anesthesia 81 (100
Cardiopulmonary bypass 27 (60)
Endograft brand
Medtronic Talenta . . .
Gore Excluderb . . .
Gore TAGb . . .
Handmade or other . . .
Missing . . .
Endograft diameter, mm . . .
Endograft length, mm . . .
SD, Standard deviation; TEVAR, endovascular thoracic aortic aneurysm rep
aMedtronic, Minneapolis, Minn.
bW. L. Gore and Associates, Flagstaff, Ariz.(34.6%, in particular before 1999), or anatomy for wasunsuitable for endovascular repair in the remaining 11
(13.6%). TEVAR was preferred rather than open repair
because of emergency in 82 patients (57.3%), comorbidi-
ties in 53 (37.1%), and TEVAR was simply the institution’s
standard treatment for all descending thoracic aortic pa-
thologies in the remaining 8 (5.6%).
Early mortality. The 30-day mortality was signifi-
cantly lower in patients treated with TEVAR for rDTAA
than in patients treated with open repair: 27 of 143 (18.9%)
vs 27 of 81 (33.3%); OR, 2.15 (95% CI, 1.15-4.01; P 
.016). Data regarding the cause of 30-day mortality were
available in 42 of 54 deaths (78%, Table I). The most
frequent causes of 30-day mortality after open repair were
exsanguination, cardiac complications, or stroke, which
were each responsible for 5 of 18 deaths (27.7%, Fig 1).
Besides these, multiorgan failure (MOF) and infectious
complications were common causes of death in the TEVAR
group. Mean interval between aneurysm repair and death
30 days was 2.1 days after open repair vs 7.8 days after
TEVAR (P  .022).
Early complications. MI was reported in 5 of 45
patients (11.1%) after open repair and in 5 of 142 patients
(3.5%) after TEVAR (OR, 3.5; 95% CI, 1.02-13.37; P 
.047; Table III). Stroke occurred in 6 of 59 patients
(10.2%) in the open repair group vs 5 of 123 patients
(4.1%) in the TEVAR group (OR, 2.67; P .117). Inmost
cases, these complications resulted in death. Permanent
paraplegia was reported in 4 of 73 (5.5%) after open repair
and in 4 of 130 (3.1%) after TEVAR (OR, 1.83; P .405).
Additional vascular interventions 30 days were de-
scribed in 11 of 121 patients (9.1%) after TEVAR vs 1 of 44
cending thoracic aortic aneurysm
1) TEVAR (n  143)
PD no. (%) or mean  SD




8 (5.6) . . .
82 (57.3) . . .
53 (37.1) . . .
0 (0) . . .
0 (0) . . .
106 (80.9) .201
92 (95.8) .063
. . . . . .
46 (32.2) . . .
21 (14.7) . . .
12 (8.4) . . .
15 (10.5) . . .
49 (34.3) . . .
37  0.7 . . .











air.patients (2.3%) after open repair (OR, 0.23; P  .169).
sms w
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common iliac artery, external iliac artery, or femoral artery
in 5 patients, conversion to open repair because of proximal
endoleak in 2, additional TEVAR because of type 1 en-
doleak in 2, and carotid-carotid bypass in 1 because of
overstenting of the left carotid artery. One re-exploration
for bleeding after open repair of rDTAA was reported.
Endoleak was reported in 10 of 90 patients (11.1%) at some
point during follow-up after TEVAR, which included type
I endoleak in 9 and type II endoleak in 1. Endograft
migration was reported once.
Death during follow-up. Reliable data regarding
deaths during follow-up were available for 107 of the 116
TEVAR patients (92%) who were alive 30 days and for 9
of 52 (17%) in the open repair group. Median follow-up
was 17  10 months for the TEVAR group and 36  13
months for the open repair group. In the TEVAR group,
five patients died of aneurysm-related causes after 30-days;
Fig 1. Causes of 30-day mortality after endovascular rep
open repair. Other causes of death were iatrogenic diss
superior mesentery artery infarction after TEVAR (n 
descending thoracic aortic aneurysm.
Table III. Thirty-day outcomes of open repair and thorac
thoracic aortic aneurysms
Outcome
Open repair (n  81)
no. (%)
30-day mortality 27 (33.3)
Myocardial infarction 5 (11.1)
Stroke 6 (10.2)
Paraplegiaa 4 (5.5)
Additional vascular interventionb 1 (2.3)
CI, Confidence interval; OR, odds ratio; TEVAR, endovascular thoracic ao
aPatients who sustained permanent paraplegia after ruptured descending th
bIncluded conversion to open repair because of proximal endoleak (n 2), r
5), additional TEVAR because of type 1 endoleak (n 2), and carotid-carot
for bleeding after open repair of ruptured descending thoracic aortic aneurythe median time interval until death was 139 days (range,87-1080 days). Exsanguination due to rupture of the
stented aneurysm or the adjacent aortic segment was the
cause of death in four patients. Untreated type 1 endoleak
caused the rupture in two cases, perforation of the aortic
wall by the bare portion of the stent-graft occurred once,
and an infected stent graft led to aortic rupture in the last
patient. The fifth aneurysm-related death during TEVAR
follow-up was the result of sepsis due to an aortobronchial
fistula. The estimated aneurysm-related survival for patients
treated with TEVAR was 70.6% after 3 years (Fig 2). No
aneurysm-related deaths were reported in the open repair
group during follow-up.
DISCUSSION
This review of the available literature found that
TEVAR of rDTAA was associated with a significantly lower
30-day mortality rate compared with open repair. The
5-year survival rate of patients with untreated TAAs is only
f thoracic aortic aneurysms (TEVAR) are compared with
n with abdominal malperfusion after TEVAR (n  1),
and acute renal failure after open repair of a ruptured
dovascular aneurysm repair for ruptured descending
TEVAR (n  143)
OR (95% CI) Pno. (%)
27 (18.9) 2.15 (1.15-4.01) .016
5 (3.5) 3.70 (1.02-13.4) .047
5 (4.1) 2.67 (0.78-9.14) .117
4 (3.1) 1.83 (0.44-7.53) .405
11 (9.1) 0.23 (0.03-1.86) .169
eurysm repair.
aortic aneurysm repair.
f a ruptured common iliac artery, external iliac artery or femoral artery (n
ass because of overstenting of the left carotid artery (n 1). Re-exploration






id byp20% to 54%,39,40 which is primarily the result of aneurysm
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female gender, chronic obstructive pulmonary disease
(COPD), and most importantly, increasing TAA diame-
ter.40-43 For TAAs 6 cm in diameter, risks of dissection,
rupture or death are about 15% per year.40,42 Because these
risks substantially exceed the risk of surgical resection of
TAA, elective intervention is generally recommended in
aneurysms6 cm.42,44-46 Among patients with rTAAs, the
overall mortality approaches 100%, and just a few of these
patients will be admitted alive to the emergency depart-
ment.1 Although patients who arrive at the hospital alive
are thought to have a more realistic outcome, a large
portion of this group will not survive the operation.47
The traditional treatment of rDTAA has been open
surgical resection of the aneurysm and replacement with an
interposition graft. Since the introduction of endovascular
techniques for the management of abdominal and thoracic
aortic disease, this less invasive technique has improved
operative mortality rates of elective and emergency inter-
ventions compared with open surgical repair.5-11,48 Signif-
icant benefits of endovascular repair have not yet been re-
ported for rDTAA, which likely is the result of the relatively
low incidence of this disease. To our knowledge, the largest
comparative study evaluated30 patients with rDTAA.21 In
addition, studies often combine results of rDTAA, trau-
matic aortic injuries, penetrating aortic ulcers, and type B
dissections, even though these are completely different
pathologies.
In this evaluation, the 30-day mortality was 33% after
Fig 2. Aneurysm-related survival in patients treated w
ruptured descending thoracic aortic aneurysm. The esti
70.6%. The red dashed line indicates 30 days after the en
for patients treated with open repair because the follow-open repair of rDTAA compared with 19% after TEVAR.Open repair of rDTAA is a more invasive procedure than
TEVAR, and patients treated with open repair appeared to
present more frequently with MI, stroke, and paraplegia
during or shortly after the operation. MI and stroke were
important causes of death after open repair. TEVAR does
not require thoracotomy, aortic clamping, or cardiopulmo-
nary bypass and offers prompt exclusion of the ruptured
aneurysm, which minimizes additional blood loss. These
advantageous characteristics of endovascular management
of rDTAA appear to result in superior short-term outcomes
compared with open repair, and TEVAR may therefore be
the treatment of first choice in patients with rDTAA.
The cause of concern with endovascular repair of aortic
disease remains its durability and the development of
endograft-related complications.49 Endoleak was present
in at least 11% after TEVAR, and during a median
follow-up of 17months, 5 of the 107 TEVAR patients with
available follow-up data had died of endograft-related com-
plications, and the estimated aneurysm-relate survival at 3
years was 71%. Rupture of the stented aneurysm or the adja-
cent aorta was the main cause of death in these patients, and
was caused by type 1 endoleak, perforation of the aortic wall
by the bare portion of the stent graft, or an infected stent graft.
Risks of endograft-related complications may be in-
creased after emergency procedures, because physicians in
this setting can only use those endografts that are available
on the shelf stock, and urgent situations may not allow
optimal endograft sizing and deployment. Furthermore,
hypovolemic shock may result in an decreased aortic diam-
horacic endovascular aneurysm repair (TEVAR) for a
aneurysm-related survival at 3 years after TEVAR was
cular procedure. Survival estimates were not performed
ta were not available for 83% of patients.ith t
mated
dovaseter, which may also contribute to inadequate endograft
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puted tomography angiography after TEVAR, and further
improvement of endovascular techniques and endografts
design is required.21,49
Meta-analyses such as the present study have several
limitations; the most important disadvantage is that the
data are limited to information provided by the original
articles. This can result in incomplete data, such as the
follow-up data that was unavailable for most of the patients
treated with open repair.
Furthermore, there was a tendency for TEVAR to be
used more frequently for aneurysms with a contained rup-
ture rather than for those with a free rupture. Blood loss
may be more extensive in case of free rupture, which could
result in hemodynamic instability and poorer outcomes.
However, data regarding this variable were missing in 15%
as well.
In addition, some complications or even deaths may
have been under-reported in the evaluated studies. Articles
in which the description of the outcome variables was
unclear were therefore excluded from the meta-analysis.
The present study does represent the largest evaluation of
patients with rDTAA treated with TEVAR and open repair,
and it may offer the best evidence that is currently available
regarding the management of this life-threatening disease.
CONCLUSION
Published reports indicate that endovascular repair of
rDTAA is associated with a significantly lower 30-day mor-
tality rate compared with open surgical repair. Further-
more, complications such as MI, stroke, and paraplegia
appear to be lower after endovascular repair of rDTAA.
However, endovascular repair was associated with a consid-
erable number of aneurysm-related deaths during follow-
up, mainly caused by late rupture after TEVAR. Continued
surveillance after TEVAR and further improvement of the
design of endografts is required to decrease the endograft-
related complications and deaths during follow-up.
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